See the below website for a summary of some recent evidence that indicates that naloxone administered through a nasal spray has the same effectivess in averting overdose death as compared to naloxone administered by needle (i.e. intramuscular injection).
http://updates.pain-topics.org/2009/12/intranasal-naloxone-overcoming-opioid.html
PSI programs distributing naloxone should consider if switching to nasal sprays is a practical, affordable, acceptable option for their intervention sites.
Contact me (robgray@laopdr.com) or Petra (pstankard@psi.org) for more information.
Rob
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment